Janssen explains why it paid Dr. Drew Pinsky

Dear Mr. Romenesko,

We at Janssen Pharmaceuticals, Inc. saw your blog post today on the consulting fees paid to Dr. Drew in 2010 and 2011. We worked with Dr. Drew to develop content and speak about Smart Moves, Smart Choices.

Janssen Pharmaceuticals, Inc. has been very pleased to collaborate with the National Association of School Nurses (NASN) and Dr. Drew on Smart Moves, Smart Choices, which is a program aimed at educating teens, parents and educators about the prevalence and serious risks of teen prescription drug abuse in the U.S., which–as you probably know–is a serious and growing problem impacting our young people today.

In fact, in 2010, 1 in 4 teens reported having abused a prescription medication, which is up from the 1 in 5 teens that reported in 2009.

I invite you to take a look at the web site linked above and both of the announcements linked here about the program and the resources it offers:

Dr. Drew Joins the National Association of School Nurses and PriCara® to Address America’s Problem of Teen Prescription Drug Abuse | LINK

(Note: PriCara® was an operating unit within Ortho McNeil Janssen Pharmaceuticals, which changed its name in the summer of 2011. Now, we are known as Janssen Pharmaceuticals, Inc.)

Dr. Drew Pinsky Joins NASN to Launch School Tool Kit Addressing Teen Prescription Drug Abuse | LINK

Thank you for your consideration of this information, and please let us know if we can answer any questions you may have about Smart Moves, Smart Choices and our work with Dr. Drew.


Jeff Christensen
Manager, Product Communication
Global Pharmaceuticals Communication & Public Affairs